Literature DB >> 19182818

Portfolio analysis and R&D decision making.

Richard Evans, Scott Hinds, Denise Hammock.   

Abstract

Mesh：

Year:  2009        PMID： 19182818     DOI： 10.1038/nrd2744

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  4 in total

1.  Identifying problematic drugs based on the characteristics of their targets.

Authors:  Tiago J S Lopes; Jason E Shoemaker; Yukiko Matsuoka; Yoshihiro Kawaoka; Hiroaki Kitano
Journal:  Front Pharmacol       Date:  2015-09-01       Impact factor: 5.810

2.  Prioritizing investments in rapid response vaccine technologies for emerging infections: A portfolio decision analysis.

Authors:  Dimitrios Gouglas; Kevin Marsh
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

Review 3.  New business models for antibiotic innovation.

Authors:  Anthony D So; Tejen A Shah
Journal:  Ups J Med Sci       Date:  2014-03-19       Impact factor: 2.384

4.  Honing the Priorities and Making the Investment Case for Global Health.

Authors:  Trevor Mundel
Journal:  PLoS Biol       Date:  2016-03-02       Impact factor: 8.029
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.